Skip to main content
Premium Trial:

Request an Annual Quote

Oliver Bayliss, Norma Jean Nowak

Premium

BioWisdom has appointed Oliver Bayliss as director of sales and business development. Bayliss, who has over ten years of sales experience at Viaken Systems, Accelrys, GCG, Oxford Molecular, and DNAStar, will spearhead the expansion of the company’s worldwide direct sales operation. He will also develop and manage BioWisdom’s channel strategies to deliver the company’s ontologies through a range of third-party tools.

 

Norma Jean Nowak has been named director of scientific planning for the University at Buffalo Center of Excellence in Bioinformatics. Since 1999, Nowak served as director of the microarray and genomics facility for Roswell Park Cancer Institute and the UB School of Medicine and Biomedical Sciences. Prior to that, she spent 14 years at Roswell Park developing physical clone resources for cloning disease genes and mapping the human genome.

Filed under

The Scan

Tennessee's COVID-19 Sequencing

The Tennessean reports that a state lab there can now run its own genome sequencing analyses of SARS-CoV-2 samples.

Sanction Violation Charges

A former professor has been charged with exporting genetic sequencing equipment to Iran in violation of US sanctions, the Miami Herald reports.

Prenetics to Go Public Through SPAC

Prenetics, a Hong Kong-based genomic and diagnostic company, is going public through a SPAC merger, according to 360Dx.

Nature Papers Examine Genomes of Centenarians, Transcription-Coupled DNA Repair

In Nature this week: analysis of centenarian genomes uncovers longevity-linked variants, and more.